Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+1K
-
Total reported value, excl. options
-
$107M
-
Value change
-
+$5K
-
Number of buys
-
1
-
Price
-
$4.63
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q4 2013
40 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q4 2013.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
.
Largest 10 shareholders include Broadfin Capital, LLC (3.55M shares), MILLENNIUM MANAGEMENT LLC (3.39M shares), HealthCor Management, L.P. (3.35M shares), BAKER BROS. ADVISORS LP (3.17M shares), NATIXIS (3.15M shares), VANGUARD GROUP INC (1.09M shares), DIMENSIONAL FUND ADVISORS LP (978K shares), Ghost Tree Capital, LLC (550K shares), EAM Investors, LLC (542K shares), and BANK OF AMERICA CORP /DE/ (480K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.